• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上调 microRNA-496 通过靶向 eIF4E 抑制人骨肉瘤细胞的增殖、侵袭、迁移和体内致瘤性。

Up-regulation of microRNA-496 suppresses proliferation, invasion, migration and in vivo tumorigenicity of human osteosarcoma cells by targeting eIF4E.

机构信息

The Third Department of Orthopedics, The Fifth Hospital of Harbin, Harbin, 150040, Heilongjiang Province, PR China.

Operating Theater, The Fifth Hospital of Harbin, Harbin, 150040, Heilongjiang Province, PR China.

出版信息

Biochimie. 2019 Aug;163:1-11. doi: 10.1016/j.biochi.2019.04.017. Epub 2019 Apr 16.

DOI:10.1016/j.biochi.2019.04.017
PMID:30998968
Abstract

Osteosarcoma is an aggressive bone tumor characterized by a high level of genetic instability and recurring DNA deletions and amplifications. This study aims to investigate how microRNA-496 (miR-496) affects proliferation, invasion, and migration of human osteosarcoma (OS) cells and in vivo tumorigenicity by targeting eukaryotic translation initiation factor 4E (eIF4E). Microarray-based gene expression profiling involving OS was used in order to identify differentially expressed genes. After that, the interaction between miR-496 expression and OS patients' survival rate was determined. The expression pattern of miR-496 and eIF4E was determined in OS tissues and cells, and their potential relationship was further analyzed by using the dual luciferase reporter gene assay. With the purpose of identifying the functional role miR-496 in OS, cell proliferation, migration, and invasion were measured in cells treated with miR-496 mimic or inhibitor. A nude mouse model was constructed in order to investigate the regulatory effects of miR-496 on tumor growth in vivo by regulating eIF4E. OS cells exhibited a down-regulated expression of miR-496 and an up-regulated expression of eIF4E. miR-496 expression was positively correlated to OS patients' survival rate. Bioinformatics analysis suggested eIF4E would be a direct target of miR-496, and the expression of eIF4E was inhibited by overexpression of miR-496. miR-496 elevation was found to exert suppressive effects on OS cell proliferation, migration and invasion in vitro and tumor growth in vivo, with the effects being reversed using miR-496 depletion. Altogether, the above findings support a conclusion that miR-496 could work as a tumor suppressor in OS through down-regulation of eIF4E. This study may provide a novel target for treatment of OS.

摘要

骨肉瘤是一种具有高水平遗传不稳定性和反复出现的 DNA 缺失和扩增的侵袭性骨肿瘤。本研究旨在通过靶向真核翻译起始因子 4E(eIF4E)来研究 microRNA-496(miR-496)如何影响人骨肉瘤(OS)细胞的增殖、侵袭和迁移以及体内肿瘤生成能力。使用基于微阵列的基因表达谱分析来鉴定差异表达基因。之后,确定 miR-496 表达与 OS 患者生存率之间的相互作用。确定 miR-496 和 eIF4E 在 OS 组织和细胞中的表达模式,并通过双荧光素酶报告基因检测进一步分析它们之间的潜在关系。为了确定 miR-496 在 OS 中的功能作用,在转染 miR-496 模拟物或抑制剂的细胞中测量细胞增殖、迁移和侵袭。构建裸鼠模型,通过调节 eIF4E 来研究 miR-496 在体内对肿瘤生长的调节作用。OS 细胞表现出 miR-496 的下调表达和 eIF4E 的上调表达。miR-496 的表达与 OS 患者的生存率呈正相关。生物信息学分析表明 eIF4E 是 miR-496 的直接靶标,miR-496 的过表达抑制了 eIF4E 的表达。发现 miR-496 升高可在体外抑制 OS 细胞的增殖、迁移和侵袭,并在体内抑制肿瘤生长,而 miR-496 耗竭则逆转了这些作用。总之,上述发现表明 miR-496 可通过下调 eIF4E 在 OS 中发挥肿瘤抑制作用。本研究可能为 OS 的治疗提供新的靶点。

相似文献

1
Up-regulation of microRNA-496 suppresses proliferation, invasion, migration and in vivo tumorigenicity of human osteosarcoma cells by targeting eIF4E.上调 microRNA-496 通过靶向 eIF4E 抑制人骨肉瘤细胞的增殖、侵袭、迁移和体内致瘤性。
Biochimie. 2019 Aug;163:1-11. doi: 10.1016/j.biochi.2019.04.017. Epub 2019 Apr 16.
2
Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.下调 microRNA-31-5p 通过增强 AXIN1 抑制骨肉瘤细胞的增殖和侵袭,通过 Wnt/β-catenin 信号通路。
Exp Mol Pathol. 2019 Jun;108:32-41. doi: 10.1016/j.yexmp.2019.03.001. Epub 2019 Mar 4.
3
MicroRNA-185 inhibits proliferation, migration and invasion in human osteosarcoma MG63 cells by targeting vesicle-associated membrane protein 2.微小 RNA-185 通过靶向囊泡相关膜蛋白 2 抑制人骨肉瘤 MG63 细胞的增殖、迁移和侵袭。
Gene. 2019 May 15;696:80-87. doi: 10.1016/j.gene.2019.01.034. Epub 2019 Feb 2.
4
MicroRNA-204 inhibits proliferation, migration, invasion and epithelial-mesenchymal transition in osteosarcoma cells via targeting Sirtuin 1.微小RNA-204通过靶向沉默调节蛋白1抑制骨肉瘤细胞的增殖、迁移、侵袭及上皮-间质转化。
Oncol Rep. 2015 Jul;34(1):399-406. doi: 10.3892/or.2015.3986. Epub 2015 May 19.
5
miR-134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP1 and MMP3 in vitro and in vivo.miR-134 通过靶向 MMP1 和 MMP3 在体外和体内抑制骨肉瘤细胞的侵袭和转移。
FEBS Lett. 2019 May;593(10):1089-1101. doi: 10.1002/1873-3468.13387. Epub 2019 May 8.
6
Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.miR-664的过表达通过靶向SOX7与骨肉瘤细胞迁移和侵袭能力增强相关。
Clin Exp Med. 2017 Feb;17(1):51-58. doi: 10.1007/s10238-015-0398-6. Epub 2015 Oct 29.
7
miR-624-5p promoted tumorigenesis and metastasis by suppressing hippo signaling through targeting PTPRB in osteosarcoma cells.miR-624-5p 通过靶向 PTPRB 抑制 hippo 信号通路促进骨肉瘤细胞的发生和转移。
J Exp Clin Cancer Res. 2019 Dec 11;38(1):488. doi: 10.1186/s13046-019-1491-6.
8
MicroRNA-1301 inhibits migration and invasion of osteosarcoma cells by targeting BCL9.MicroRNA-1301 通过靶向 BCL9 抑制骨肉瘤细胞的迁移和侵袭。
Gene. 2018 Dec 30;679:100-107. doi: 10.1016/j.gene.2018.08.078. Epub 2018 Aug 30.
9
Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway.微小RNA-206通过AKT信号通路靶向膜联蛋白A2对骨肉瘤细胞增殖、凋亡、迁移和侵袭的影响
Cell Physiol Biochem. 2018;45(4):1410-1422. doi: 10.1159/000487567. Epub 2018 Feb 15.
10
MiR-127-3p inhibits cell growth and invasiveness by targeting ITGA6 in human osteosarcoma.miR-127-3p 通过靶向 ITGA6 抑制人骨肉瘤细胞的生长和侵袭。
IUBMB Life. 2018 May;70(5):411-419. doi: 10.1002/iub.1710. Epub 2018 Mar 23.

引用本文的文献

1
Plasma microRNA Profiling in Type 2 Diabetes Mellitus: A Pilot Study.2 型糖尿病患者血浆 microRNA 谱分析:一项初步研究。
Int J Mol Sci. 2023 Dec 12;24(24):17406. doi: 10.3390/ijms242417406.
2
Functional Role of RBP in Osteosarcoma: Regulatory Mechanism and Clinical Therapy.RBP 在骨肉瘤中的功能作用:调控机制与临床治疗。
Anal Cell Pathol (Amst). 2023 Jun 30;2023:9849719. doi: 10.1155/2023/9849719. eCollection 2023.
3
Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis.
骨肉瘤生长中的信号通路和 microRNAs 以及间充质干细胞在致癌中的双重作用。
Int J Mol Sci. 2023 May 19;24(10):8993. doi: 10.3390/ijms24108993.
4
Osteosarcoma and Metastasis.骨肉瘤与转移
Front Oncol. 2021 Dec 10;11:780264. doi: 10.3389/fonc.2021.780264. eCollection 2021.
5
Eukaryotic initiating factor eIF4E is targeted by EBV-encoded miR-BART11-3p and regulates cell cycle and apoptosis in EBV-associated gastric carcinoma.真核起始因子 eIF4E 是 EBV 编码的 miR-BART11-3p 的靶标,调节 EBV 相关胃癌中的细胞周期和凋亡。
Virus Genes. 2021 Aug;57(4):358-368. doi: 10.1007/s11262-021-01854-9. Epub 2021 Jun 19.
6
Serum long non‑coding RNA NNT‑AS1 protected by exosome is a potential biomarker and functions as an oncogene via the miR‑496/RAP2C axis in colorectal cancer.血清长链非编码 RNA NNT-AS1 通过外泌体保护是结直肠癌的一种潜在生物标志物,并通过 miR-496/RAP2C 轴发挥癌基因作用。
Mol Med Rep. 2021 Aug;24(2). doi: 10.3892/mmr.2021.12224. Epub 2021 Jun 16.
7
NNT-AS1 modulates prostate cancer cell proliferation, apoptosis and migration through miR-496/DDIT4 axis.NNT-AS1通过miR-496/DDIT4轴调节前列腺癌细胞的增殖、凋亡和迁移。
Cancer Cell Int. 2020 Sep 24;20:463. doi: 10.1186/s12935-020-01505-3. eCollection 2020.
8
Identification of potential crucial genes and key pathways in osteosarcoma.鉴定骨肉瘤中的潜在关键基因和关键途径。
Hereditas. 2020 Jul 14;157(1):29. doi: 10.1186/s41065-020-00142-0.
9
LINC00689 promotes prostate cancer progression via regulating miR-496/CTNNB1 to activate Wnt pathway.LINC00689通过调控miR-496/CTNNB1激活Wnt信号通路促进前列腺癌进展。
Cancer Cell Int. 2020 Jun 5;20:215. doi: 10.1186/s12935-020-01280-1. eCollection 2020.
10
MicroRNA-496 suppresses tumor cell proliferation by targeting BDNF in osteosarcoma.微小RNA-496通过靶向骨肉瘤中的脑源性神经营养因子抑制肿瘤细胞增殖。
Exp Ther Med. 2020 Feb;19(2):1425-1431. doi: 10.3892/etm.2019.8356. Epub 2019 Dec 19.